---
title: Ciprofloxacin + Phenazopyridine
description: >-
  This combination is prescribed for the symptomatic relief of urinary tract
  infections (UTIs).  Ciprofloxacin is used to treat bacterial infections while
  phenazopyridine helps with the pain caused by a UTI.
is_banned: false
lastModified: '2025-09-22T17:22:08.796Z'
faqs:
  - q: >-
      What is the recommended dosage for Ciprofloxacin + Phenazopyridine?**


      **A:** Adults: Ciprofloxacin 250-750mg every 12 hours, Phenazopyridine
      200mg three times a day for a maximum of two days.  Children:
      Ciprofloxacin use should be avoided; if prescribed, dose should be
      weight-based. Phenazopyridine use isn't established. See detailed Dosage
      section above.
    a: >-
      A:** Adults: Ciprofloxacin 250-750mg every 12 hours, Phenazopyridine 200mg
      three times a day for a maximum of two days.  Children: Ciprofloxacin use
      should be avoided; if prescribed, dose should be weight-based.
      Phenazopyridine use isn't established. See detailed Dosage section above.
  - q: >-
      Can this combination be used in patients with kidney disease?**


      **A:** Ciprofloxacin requires dose adjustment in renal impairment.
      Phenazopyridine is contraindicated.
    a: >-
      A:** Ciprofloxacin requires dose adjustment in renal impairment.
      Phenazopyridine is contraindicated.
  - q: >-
      Are there any serious side effects I should be aware of?**


      **A:** Yes.  Ciprofloxacin: Tendon rupture, seizures, peripheral
      neuropathy. Phenazopyridine: Hemolytic anemia, methemoglobinemia.
    a: >-
      A:** Yes.  Ciprofloxacin: Tendon rupture, seizures, peripheral neuropathy.
      Phenazopyridine: Hemolytic anemia, methemoglobinemia.
  - q: >-
      Can pregnant or breastfeeding women take this combination?**


      **A:**  Both drugs should be used cautiously if benefits outweigh risks.
      Safer alternatives may be preferred. Consult specialist before
      prescribing.
    a: >-
      A:**  Both drugs should be used cautiously if benefits outweigh risks.
      Safer alternatives may be preferred. Consult specialist before
      prescribing.
  - q: >-
      What are the common drug interactions with this combination?**


      **A:** Ciprofloxacin interacts with theophylline, warfarin, tizanidine,
      NSAIDs, and antacids. Phenazopyridine has no major documented interactions
      with ciprofloxacin.
    a: >-
      A:** Ciprofloxacin interacts with theophylline, warfarin, tizanidine,
      NSAIDs, and antacids. Phenazopyridine has no major documented interactions
      with ciprofloxacin.
  - q: >-
      How long should phenazopyridine be used for UTI pain relief?**


      **A:**  No more than two days due to the risk of methemoglobinemia and
      hemolytic anemia.
    a: >-
      A:**  No more than two days due to the risk of methemoglobinemia and
      hemolytic anemia.
  - q: >-
      What should I monitor in patients taking this combination?**


      **A:**  Renal and liver function, signs of tendinitis, blood glucose
      (diabetics), complete blood count.
    a: >-
      A:**  Renal and liver function, signs of tendinitis, blood glucose
      (diabetics), complete blood count.
  - q: >-
      Is this combination available as a single medication?**


      **A:**  No, ciprofloxacin and phenazopyridine are typically prescribed
      separately.
    a: >-
      A:**  No, ciprofloxacin and phenazopyridine are typically prescribed
      separately.
  - q: >-
      Can ciprofloxacin be used in children?**


      **A:**  Use is generally avoided in children unless benefits clearly
      outweigh the risks due to concerns about effects on developing cartilage.
      If prescribed, doses should be weight based.
    a: >-
      A:**  Use is generally avoided in children unless benefits clearly
      outweigh the risks due to concerns about effects on developing cartilage.
      If prescribed, doses should be weight based.
  - q: >-
      Can this combination mask the symptoms of other underlying conditions?**


      **A:**  Yes, Phenazopyridine can alter urine color and laboratory tests,
      making the diagnosis of some conditions more challenging.
    a: >-
      A:**  Yes, Phenazopyridine can alter urine color and laboratory tests,
      making the diagnosis of some conditions more challenging.
---
## **Usage**

This combination is prescribed for the symptomatic relief of urinary tract infections (UTIs).  Ciprofloxacin is used to treat bacterial infections while phenazopyridine helps with the pain caused by a UTI.

* **Pharmacological Classification:** 
    * Ciprofloxacin: Antibiotic (Fluoroquinolone)
    * Phenazopyridine: Urinary analgesic

* **Mechanism of Action:**
    * Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV, essential for bacterial DNA replication and repair, leading to bacterial cell death.
    * Phenazopyridine: Exerts a local analgesic effect on the urinary tract mucosa.

## **Alternate Names**

This drug combination isn't marketed under a specific brand name. It usually involves prescribing Ciprofloxacin and Phenazopyridine separately.


*   Ciprofloxacin brand names: Cipro, Cipro XR
*   Phenazopyridine brand names: Pyridium, Azo-Standard, Phenazo, Uristat


## **How It Works**

* **Pharmacodynamics (Ciprofloxacin):**  Ciprofloxacin targets bacterial DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and repair. This leads to bacterial cell death. It is effective against a wide range of gram-negative and some gram-positive bacteria.

* **Pharmacokinetics (Ciprofloxacin):**
    * Absorption: Well-absorbed orally, bioavailability reduced by antacids and dairy.
    * Metabolism: Partially hepatic.
    * Elimination: Primarily renal.

* **Pharmacodynamics (Phenazopyridine):** Acts locally on the urinary tract mucosa, providing analgesic relief from pain, burning, and urgency associated with UTIs.

* **Pharmacokinetics (Phenazopyridine):**
    * Absorption: Readily absorbed following oral administration.
    * Metabolism: Primarily hepatic.
    * Elimination: Primarily renal excretion, giving urine an orange/red color.

## **Dosage**



### **Standard Dosage**

#### **Adults:**

*   **Ciprofloxacin:** 250-750 mg orally every 12 hours or 400 mg IV every 8-12 hours for 7-14 days depending on the infection.
*   **Phenazopyridine:** 200 mg orally three times a day, after meals, for a maximum of two days. Administer with antibiotic therapy, not as a standalone treatment.

#### **Children:**

*   **Ciprofloxacin:** Generally avoided unless benefits outweigh risks due to concerns about cartilage development. Dosage is weight-based if prescribed: 10 to 20 mg/kg every 12 hours for 10 to 21 days, not exceeding 750 mg/day.
*   **Phenazopyridine:** Not established for use in children under 18 years old.  If prescribed, the dosage is weight-based: 4 mg/kg three times a day.

#### **Special Cases:**

*   **Elderly Patients:** Ciprofloxacin dose adjustment may be necessary based on creatinine clearance.  Phenazopyridine should be used cautiously due to age-related decline in renal function.
*   **Patients with Renal Impairment:** Ciprofloxacin dosage should be reduced based on creatinine clearance. Phenazopyridine is contraindicated in moderate to severe renal impairment.
*   **Patients with Hepatic Dysfunction:** No dosage adjustments are typically needed for ciprofloxacin. Use phenazopyridine with caution.
*   **Patients with Comorbid Conditions:** Monitor diabetics for blood glucose changes, use cautiously in patients with myasthenia gravis, assess for QT prolongation.


### **Clinical Use Cases**

Dosing for UTIs is covered in the Standard Dosage section, as this is the primary indication for the combination. The doses below are for ciprofloxacin alone, as phenazopyridine isn't indicated for these conditions.


* **Intubation:**  Ciprofloxacin is not typically used for intubation procedures alone.
* **Surgical Procedures:**  Ciprofloxacin can be used as a prophylactic antibiotic for certain surgical procedures, typically at a dose of 400mg IV, 30-60 minutes prior to surgery.
* **Mechanical Ventilation:** Ciprofloxacin is not indicated for mechanical ventilation itself but is used to treat infections in ventilated patients, following the usual dosing guidelines.
* **Intensive Care Unit (ICU) Use:** Dosing based on infection, usually higher doses and IV administration.
* **Emergency Situations:** Dosing is guided by the specific infection and patient status. High doses may be necessary.



### **Dosage Adjustments**

* **Renal/Hepatic dysfunction:** as mentioned above.
* **Metabolic disorders:**  No specific adjustments other than monitoring, unless they affect renal or hepatic function.
* **Genetic polymorphisms:**  No specific adjustments documented.


## **Side Effects**

### **Common Side Effects**

*   Nausea
*   Diarrhea
*   Headache
*   Dizziness
*   Changes in urine color (orange/red with phenazopyridine)

### **Rare but Serious Side Effects**

* Tendon rupture (ciprofloxacin)
* Seizures (ciprofloxacin)
* Peripheral neuropathy (ciprofloxacin)
* Hemolytic anemia (phenazopyridine)
* Methemoglobinemia (phenazopyridine)
* Hepatic dysfunction (both drugs)
* Renal impairment (both drugs)

### **Long-Term Effects**

*   Peripheral neuropathy (ciprofloxacin)
*   Tendon damage (ciprofloxacin)

### **Adverse Drug Reactions (ADR)**

* Angioedema (ciprofloxacin)
* Anaphylaxis (ciprofloxacin)
* Stevens-Johnson Syndrome (ciprofloxacin)


## **Contraindications**

* Ciprofloxacin: Hypersensitivity to ciprofloxacin or other fluoroquinolones, history of tendon rupture with fluoroquinolones, myasthenia gravis.
* Phenazopyridine: Hypersensitivity, renal impairment, severe liver disease, G6PD deficiency.

## **Drug Interactions**

* **Ciprofloxacin:**  Theophylline, warfarin, tizanidine, NSAIDs, dairy products, antacids, caffeine.
* **Phenazopyridine:** No well-documented, clinically significant drug interactions when used in combination with ciprofloxacin.



## **Pregnancy and Breastfeeding**

* **Ciprofloxacin:** Not generally recommended during pregnancy unless benefits clearly outweigh risks. Compatible with breastfeeding if the infant is healthy.
* **Phenazopyridine:**  Safety during pregnancy and breastfeeding isn't well-established.  Use cautiously if benefits outweigh risks.

## **Drug Profile Summary**
* **Mechanism of Action:** Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV; Phenazopyridine: local analgesic effects on the urinary tract mucosa.
* **Side Effects:** See detailed list above.
* **Contraindications:** See detailed list above.
* **Drug Interactions:** See detailed list above.
* **Pregnancy & Breastfeeding:** Use with caution if benefits outweigh risks.
* **Dosage:** See detailed section above.
* **Monitoring Parameters:** Renal function, liver function (for extended use), signs of tendinitis/tendon rupture, blood glucose (in diabetics), complete blood count.

## **Popular Combinations**

Ciprofloxacin and phenazopyridine are often prescribed together, though it's important to note there are no fixed dose combination products. Other antibiotics for UTIs (nitrofurantoin, trimethoprim/sulfamethoxazole, fosfomycin) can be used instead of ciprofloxacin depending on various factors.


## **Precautions**

* **General Precautions:** Assess renal and hepatic function, screen for G6PD deficiency, allergies and other underlying conditions.
* **Specific Populations:**  See “Pregnancy and Breastfeeding” and “Special Cases” under Dosage.
* **Lifestyle Considerations:** Avoid alcohol and caffeine during ciprofloxacin therapy.  Driving restrictions may apply due to potential dizziness from both drugs.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Ciprofloxacin + Phenazopyridine?**

**A:** Adults: Ciprofloxacin 250-750mg every 12 hours, Phenazopyridine 200mg three times a day for a maximum of two days.  Children: Ciprofloxacin use should be avoided; if prescribed, dose should be weight-based. Phenazopyridine use isn't established. See detailed Dosage section above.

### **Q2:  Can this combination be used in patients with kidney disease?**

**A:** Ciprofloxacin requires dose adjustment in renal impairment. Phenazopyridine is contraindicated.

### **Q3:  Are there any serious side effects I should be aware of?**

**A:** Yes.  Ciprofloxacin: Tendon rupture, seizures, peripheral neuropathy. Phenazopyridine: Hemolytic anemia, methemoglobinemia.

### **Q4: Can pregnant or breastfeeding women take this combination?**

**A:**  Both drugs should be used cautiously if benefits outweigh risks. Safer alternatives may be preferred. Consult specialist before prescribing.

### **Q5: What are the common drug interactions with this combination?**

**A:** Ciprofloxacin interacts with theophylline, warfarin, tizanidine, NSAIDs, and antacids. Phenazopyridine has no major documented interactions with ciprofloxacin.

### **Q6: How long should phenazopyridine be used for UTI pain relief?**

**A:**  No more than two days due to the risk of methemoglobinemia and hemolytic anemia.

### **Q7:  What should I monitor in patients taking this combination?**

**A:**  Renal and liver function, signs of tendinitis, blood glucose (diabetics), complete blood count.

### **Q8: Is this combination available as a single medication?**

**A:**  No, ciprofloxacin and phenazopyridine are typically prescribed separately.

### **Q9: Can ciprofloxacin be used in children?**

**A:**  Use is generally avoided in children unless benefits clearly outweigh the risks due to concerns about effects on developing cartilage. If prescribed, doses should be weight based.


### **Q10: Can this combination mask the symptoms of other underlying conditions?**

**A:**  Yes, Phenazopyridine can alter urine color and laboratory tests, making the diagnosis of some conditions more challenging.

